InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by KEYSER D JEFFREY, Director. Director active across 1 companies, notably Lantern Pharma Inc.. Aggregated, 2 disclosures have been logged. Total volume traded: €170k. The latest transaction was disclosed on 12 May 2026 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
US$85,21348,544 shares@ US$1.75540.21% mcap100.0% of flow
Common stock, $0.001 par value
SEC:0001493152-26-023082·
Ideal exit: 6 Feb 2027 (T+270)
€85,21348,544 shares@ €1.75540.21% mcap50.0% of flow
Common stock, $0.001 par value
SEC:0001493152-26-023082:0·
Ideal exit: 6 Feb 2027 (T+270)
2 of 2 declarations
About KEYSER D JEFFREY
Jeffrey D. Keyser serves as a Board Member of Lantern Pharma Inc. He participates in the governance of the company by overseeing operations and contributing to strategic decision-making. His role is essential in ensuring compliance and transparency in the company's activities.
